A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice
about
The proximal signaling network of the BCR-ABL1 oncogene shows a modular organizationC3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion.Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivationDownregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cellsBCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.Emerging roles for crk in human cancer.Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML.The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABLConcise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting.The role of CT10 regulation of kinase-like in cancer.Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemiaTargeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.Antibody arrays identify protein-protein interactions in chronic myeloid leukaemia.
P2860
Q24294830-920DC93E-60EC-4CDB-A66B-986821EBCC49Q30009935-91E8F817-100D-439D-AE90-D5B5050A2CF5Q30010491-4F40BBDA-EA04-4873-970C-E7B812A3F711Q31055456-C1D71CBE-72D8-4396-B76F-7E4F2A00B727Q34551213-E6A4C390-00E5-4866-9227-8E5DEADAD66FQ34972759-C582EE2C-D546-48B2-A099-41C8B4979235Q35025461-188A9B71-DE0C-4B95-8C78-E4A9D90B3D76Q35903385-E6A375AD-245A-4C10-BD64-F4B1EADAEBD4Q37027483-C84F775C-4CB9-403B-907F-25813F1656F9Q38187388-081B1F48-BF07-4F8D-89FF-E5E41A472AD4Q38296676-9A5C506E-0AFD-43B1-91C3-680EF4EACA8FQ38673775-F1312926-28F7-40B4-AC71-A2EC7AEE0C96Q41279430-F56FCB7C-2B68-4DD0-9DE3-A6AAF2DABBC5Q54613651-847F5E2D-50FA-4DDA-8CF4-4C66E48DA2A1
P2860
A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@ast
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@en
type
label
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@ast
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@en
prefLabel
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@ast
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@en
P2093
P2860
P1433
P1476
A BCR-ABL mutant lacking direc ...... ils to induce leukemia in mice
@en
P2093
Amie S Corbin
Ian J Griswold
Kara J Johnson
Marc Loriaux
Michael W Deininger
Thomas O'Hare
P2860
P356
10.1371/JOURNAL.PONE.0007439
P407
P577
2009-10-13T00:00:00Z